Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
On September 29, 2021, the U.S. Food and Drug Administration (FDA) released a draft guidance discussing "considerations when proposing to use electronic health records (EHR) or medical claims data in clinical studies to support regulatory decisions on effectiveness and safety." 1 The guidance is a result of years of FDA consideration of use of real-world data (RWD), including many stakeholder discussions.It addresses the adequacy and relevance of RWD to address specific research questions and validation and data quality/provenance of study question elements.1 In addition, the guidance considers whether follow-up in RWD sources is sufficient to ascertain outcomes and if missing data limit interpretation of results.[1][2][3][4] Notably, FDA recommendations do not appear to be limited to new product indications or labeling changes, nor to non-interventional studies.Study design and
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2009) · doi:10.1007/978-0-387-87959-8 · Cited by 554
Cited by
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
Zang, C., Zhang, H., Xu, J., Zhang, H., Fouladvand, S., Havaldar, S., Cheng, F., Chen, K., Chen, Y., Glicksberg, B. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43929-1 · Cited by 69
“Such inconsistency highlights the necessity of leveraging different RWD data sets to derive robust and consistent evidence 42,43 .”
Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
Grabowska, M. E., Huang, A., Wen, Z., Li, B., & Wei, W.-Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1257700 · Cited by 55
Representing and utilizing clinical textual data for real world studies: An OHDSI approach
Keloth, V. K., Banda, J. M., Gurley, M., Heider, P. M., Kennedy, G., Liu, H., Liu, F., Miller, T., Natarajan, K., V Patterson, O., et al. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104343 · Cited by 16
Metadata
- Authors
- Girman, C. J., Ritchey, M. E., & Lo Re, V.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2022-05-03
- Volume
- 31
- Issue
- 7
- Pages
- 717-720
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W4224433810
- Cited by
- 152
- References
- 1
- FWCI
- 85.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products. https://app.cochat.ai/papers/10.1002/pds.5444
- The paper
- Girman, C. J., Ritchey, M. E., & Lo Re, V. (2022). Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5444
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.